Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Anika Therapeutics, Inc. | 36,163 | reported | 30 Apr 2026 | tx 14+689,915−22,537 |
| VSE CORP | 28,763 | reported | 01 Apr 2024 | tx 40+59,777−13,186 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Apr 2026 | PURCHASE | Anika Therapeutics, Inc. | 12,200 | 12.29 USD | |
| 14 Mar 2026 | EXERCISE | Anika Therapeutics, Inc. | 12,824 | — | |
| 14 Mar 2026 | TAX_WITHHOLDING | Anika Therapeutics, Inc. | 5,944 | 14.20 USD | |
| 14 Mar 2026 | GRANT_AWARD | Anika Therapeutics, Inc. | 6,412 | 0.00 USD | |
| 14 Mar 2026 | EXERCISE | Anika Therapeutics, Inc. | 12,824 | 0.00 USD | deriv |
| 01 Feb 2026 | GRANT_AWARD | Anika Therapeutics, Inc. | 130,402 | 0.00 USD | deriv |
| 01 Feb 2026 | GRANT_AWARD | Anika Therapeutics, Inc. | 310,207 | 0.00 USD | deriv |
| 03 Jun 2025 | EXERCISE | Anika Therapeutics, Inc. | 12,840 | 0.00 USD | |
| 03 Jun 2025 | TAX_WITHHOLDING | Anika Therapeutics, Inc. | 3,769 | 11.59 USD | |
| 03 Jun 2025 | EXERCISE | Anika Therapeutics, Inc. | 12,840 | 0.00 USD | deriv |
| 14 Mar 2025 | GRANT_AWARD | Anika Therapeutics, Inc. | 38,473 | 0.00 USD | deriv |
| 14 Mar 2025 | GRANT_AWARD | Anika Therapeutics, Inc. | 18,672 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | Anika Therapeutics, Inc. | 38,520 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | Anika Therapeutics, Inc. | 96,525 | 0.00 USD | deriv |
| 01 Apr 2024 | TAX_WITHHOLDING | VSE CORP | 1,160 | 79.02 USD | |
| 31 Mar 2024 | EXERCISE | VSE CORP | 1,287 | 0.00 USD | |
| 31 Mar 2024 | GRANT_AWARD | VSE CORP | 2,567 | 0.00 USD | |
| 11 Mar 2024 | TAX_WITHHOLDING | VSE CORP | 3,031 | 75.12 USD | |
| 11 Mar 2024 | GRANT_AWARD | VSE CORP | 1,821 | 0.00 USD | |
| 11 Mar 2024 | EXERCISE | VSE CORP | 1,324 | — | |
| 10 Mar 2024 | GRANT_AWARD | VSE CORP | 5,132 | 0.00 USD | |
| 10 Mar 2024 | EXERCISE | VSE CORP | 1,832 | — | |
| 11 Mar 2024 | EXERCISE | VSE CORP | 1,324 | 0.00 USD | deriv |
| 08 Mar 2024 | GRANT_AWARD | VSE CORP | 3,549 | 0.00 USD | deriv |
| 10 Mar 2024 | EXERCISE | VSE CORP | 1,832 | 0.00 USD | deriv |